Le Lézard
Classified in: Covid-19 virus

Market Outlook on the North America Cosmetic Surgery and Procedure Market to 2028 - Insights, Drivers, Opportunities and Challenges - ResearchAndMarkets.com


The "North America Cosmetic Surgery and Procedures Market 2021-2028" report has been added to ResearchAndMarkets.com's offering.

This report infers that the North American cosmetic surgery and procedures market is likely to display a growth trend at a CAGR of 6.34% in the considered years 2021-2028. The United States and Canada outline the market in this region.

Canada has a large young population opting for noninvasive procedures, owing to advantages such as lesser postoperative and lower discomfort. Moreover, the aging population is opting for these procedures. Additionally, the presence of a large percentage of women in the workforce has enhanced the demand for cosmetic services, driving the market on a growth path. Furthermore, several companies are expanding operations in the country, advancing existing technologies, product launches, and product approvals. All these factors have increased the demand for surgical procedures, thereby augmenting the growth of the cosmetic surgery and procedures market in Canada.

Likewise, numerous market players are concentrating on new products launched to gain market share in the United States. For instance, in 2020, Aptos threads named polypropylene surgical sutures threads were approved by the FDA. Other than this, changing lifestyles have increased the demand for tattoos. However, many are opting for tattoo removal procedures, which increased the demand for these procedures significantly. Thus, as stated above, all these factors are widening the scope and development of the cosmetic surgery and procedures market in the United States.

Companies Mentioned

Key Topics Covered:

1. North America Cosmetic Surgery and Procedures Market - Summary

2. Industry Outlook

2.1. Impact of Covid-19 on Cosmetic Surgery and Procedure Market

2.2. Key Insights

2.2.1. Increased Prevalence of Obesity

2.2.2. R&D Activities and Regulatory Approvals for Botulinum Toxin

2.2.3. Substantial Growth in the Availability and Provision of Minimally Invasive Treatments

2.3. Porter's Five Forces Analysis

2.3.1. Threat of New Entrants

2.3.2. Threat of Substitutes

2.3.3. Bargaining Power of Buyers

2.3.4. Bargaining Power of Suppliers

2.3.5. Threat of Competitive Rivalry

2.4. Market Attractiveness Index

2.5. Vendor Scorecard

2.6. Industry Components

2.7. Key Strategic Developments

2.7.1. Acquisitions

2.7.2. Product Launches

2.7.3. Contracts & Agreements

2.7.4. Investments & Expansions

2.8. Market Drivers

2.8.1. Technological Advancements in Cosmetic Devices and Procedures

2.8.2. Growing Acceptance of Aesthetic Procedures

2.9. Market Challenges

2.9.1. Side Effects Associated With Cosmetic Treatments

2.9.2. Lack of a Proper Reimbursement Framework

2.10. Market Opportunities

2.10.1. Increasing Number of Men Undergoing Cosmetic Procedures

2.10.2. Rising Awareness About Cosmetic Surgery Potential Benefits

3. North America Cosmetic Surgery and Procedures Market Outlook - by Type

3.1. Surgical

3.1.1. Breast Augmentation

3.1.2. Liposuction

3.1.2.1. Laser-Assisted Liposuction

3.1.2.2. Radiofrequency-Assisted Liposuction

3.1.2.3. Ultrasound-Assisted Liposuction

3.1.2.4. Other Liposuction Surgeries

3.1.3. Eyelid Surgery

3.1.4. Tummy Tuck

3.1.5. Breast Lift

3.1.6. Other Surgical Types

3.2. Non-Surgical

3.2.1. Botulinum Toxin

3.2.2. Dermal Fillers

3.2.3. Laser Hair Removal

3.2.4. Chemical Peel

3.2.5. Microdermabrasion

3.2.6. Photo-Rejuvenation

3.2.7. Other Non-Surgical Types

4. North America Cosmetic Surgery and Procedures Market - Country Outlook

4.1. United States

4.2. Canada

5. Competitive Landscape

6. Research Methodology & Scope

For more information about this report visit https://www.researchandmarkets.com/r/xw6mt3


These press releases may also interest you

at 07:15
Draganfly Inc. ("Draganfly" or the "Company"), an award-winning, industry-leading drone solutions and systems developer is pleased to announce a strategic collaboration with ParaZero Technologies Ltd., a pioneer in drone safety systems aimed at...

at 07:05
LiveWire Group, Inc. ("LiveWire" or the "Company") today reported first quarter 2024 results. "We are pleased with the successful launch of the S2 Mulholland, and with three bikes in market, we are proud that LiveWire is now the #1 on-road...

at 07:05
Newmont Corporation (Newmont or the Company) today announced first quarter 2024 results and declared a first quarter dividend of $0.25 per share. "Newmont delivered a strong first quarter operational performance, producing 2.2 million gold...

at 07:05
Can-Fite BioPharma Ltd. , a biotechnology company advancing a pipeline of proprietary small molecule drugs that address oncological and inflammatory diseases, today announced it published an article in the Experimental and Therapeutic Medicine...

at 07:03
Key takeaways Projected return on investment in pharma research and development (R&D) in 2023 has risen to 4.1%, climbing back from 2022's record low of 1.2%.The leading 20 global pharmaceutical companies collectively spent $145 billion on R&D in...

at 07:00
Harley-Davidson, Inc. ("Harley-Davidson," "HDI," or the "Company")  today reported first quarter 2024 results. "Harley-Davidson delivered a good start to the year with a six percent retail growth in North America, our largest and most important...



News published on and distributed by: